As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Wellness company Medifast (NYSE:MED) reported Q3 CY2024 results exceeding the market’s revenue expectations, but sales fell ...

Q3 2024 Earnings Call Transcript November 4, 2024 Medifast, Inc. beats earnings expectations. Reported EPS is $0.1029, ...

Fintel reports that on November 5, 2024, DA Davidson upgraded their outlook for Medifast (NYSE:MED) from Underperform to ...

Medifast's strong quarterly performance, investments in growth strategies, and undervalued stock make it an attractive ...

Greetings, and welcome to the Medifast Third Quarter 2024 Earnings Conference Call. At this time, all participants are on a listen-only mode. A brief question-and-answer session will follow the ...

Medifast Stock Performance NYSE MED opened at $19.16 on Friday. The firm has a market capitalization of $209.57 million, a P/E ratio of 29.03 and a beta of 1.13. The firm’s fifty day moving ...

Medifast ( (MED) ) has released its Q3 earnings. Here is a breakdown of the information Medifast presented to its investors. Medifast (NYSE: ...

(1) The weighted-average diluted shares outstanding used in the calculation of these non-GAAP financial measures are the same as the weighted-average shares outstanding used in the calculation of ...

BALTIMORE (AP) — BALTIMORE (AP) — Medifast Inc. (MED) on Monday reported profit of $1.1 million in its third quarter. On a per-share basis, the Baltimore-based company said it had profit of 10 ...

DA Davidson analyst Linda Bolton Weiser upgraded Medifast (MED) to Neutral from Underperform with a price target of $17, up from $16.50. With ...